| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 129, 562-564, Copyright © 1991 by Endocrine Society
ARTICLES |
J Licinio, ML Wong and PW Gold
Department of Psychiatry, Yale University School of Medicine, West Haven, Connecticut 06516.
Interleukin-1 (IL-1) is an inflammatory peptide hormone, with potent neuroendocrine effects. IL-1 stimulates the central nervous system production of corticotropin-releasing hormone (CRH), growth hormone (GH), thyroid-stimulating hormone (TSH), and somatostatin, and inhibits the secretion of prolactin and luteinizing hormone (LH). Interleukin-1 receptor antagonist (IL-1ra) is a novel cytokine, recently purified, characterized, and cloned. IL-1ra is a pure endogenous antagonist of IL- 1:IL-1 function is modulated not only by local levels of IL-1, but also by the levels of IL-1ra. We have localized by in situ hybridization histochemistry IL-1ra mRNA in rat brain, in areas of importance to neuroendocrine function, such as the paraventricular nucleus (PVN) of the hypothalamus, hippocampus, as well as cerebellum. These findings indicate that IL-1ra is produced in brain in areas of relevance to the regulation of neuroendocrine function and suggest that IL-1ra may modulate the neuroendocrine effects of IL-1.
This article has been cited by other articles:
![]() |
E Tarkowski, N Andreasen, A Tarkowski, and K Blennow Intrathecal inflammation precedes development of Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1200 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kirkwood, C. Bender, S. Agarwala, A. Tarhini, J. Shipe-Spotloe, B. Smelko, S. Donnelly, and L. Stover Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy J. Clin. Oncol., September 1, 2002; 20(17): 3703 - 3718. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tarkowski, A.-M. Liljeroth, A. Nilsson, A. Ricksten, P. Davidsson, L. Minthon, and K. Blennow TNF gene polymorphism and its relation to intracerebral production of TNF{alpha} and TNF{beta} in AD Neurology, June 13, 2000; 54(11): 2077 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Wong, P. B. Bongiorno, V. Rettori, S. M. McCann, and J. Licinio Interleukin (IL) 1beta , IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications PNAS, January 7, 1997; 94(1): 227 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, F. C. Barone, N. V. Aiyar, G. Z. Feuerstein, and G. J. del Zoppo Interleukin-1 Receptor and Receptor Antagonist Gene Expression After Focal Stroke in Rats Stroke, January 1, 1997; 28(1): 155 - 162. [Abstract] [Full Text] |
||||
![]() |
Y. Yamasaki, Y. Matsuo, N. Matsuura, H. Onodera, Y. Itoyama, and K. Kogure Transient Increase of Cytokine-Induced Neutrophil Chemoattractant, a Member of the Interleukin-8 Family, in Ischemic Brain Areas After Focal Ischemia in Rats Stroke, February 1, 1995; 26(2): 318 - 323. [Abstract] [Full Text] |
||||
![]() |
S. Reichlin Neuroendocrine-Immune Interactions N. Engl. J. Med., October 21, 1993; 329(17): 1246 - 1253. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |